Drugs / BMS747158
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | FLYRCADO | — | 2024-09-27 | fda.gov ↗ |
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT00930631 | Jun → Jul 2009 | coronary artery disorder | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase 1 | NCT00707538 | Jun → Oct 2008 | — | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase 1 | NCT00707499 | Sep 2007 → May 2008 | — | Lantheus Medical Imaging | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00849108 | Jan 2009 → Jun 2010 | ischemic disease | Lantheus Medical Imaging | Completed | Mixed |
| Phase 32 trials | ||||||
| Phase 3 | NCT01681524 | Nov 2012 → Feb 2014 | coronary artery disorder | Lantheus Medical Imaging | Withdrawn | No outcome recorded |
| Phase 3 | NCT01347710 | Jun 2011 → Jul 2013 | coronary artery disorder | Lantheus Medical Imaging | Completed | Mixed |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS747158 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00849108 ↗ |
| Known as | Flurpiridaz F18 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01681524 ↗ |
| Modality | Diagnostic / imaging agent | “a drug with small amounts of radioactivity to allow for heart imaging” NCT00849108 ↗ |
| Route | Intravenous | “IV injection” NCT00707538 ↗ |